Next-Generation Sequencing Data Market

Next?generation?sequencing?(NGS) has created a noteworthy paradigm shift in the clinical diagnostic field. It refers to an aggregate collection of methods in which various?sequencing?reactions occur at the same time, bringing about vast amounts of?sequencing?data for a little division of the cost of Sanger?sequencing.

Next-Generation Sequencing Data Market contains market size and forecasts of Next-Generation Sequencing Data Analysis in Global, including the following market information:

Global Next-Generation Sequencing Data Analysis Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Next-Generation Sequencing Data Analysis market was valued at 3797 million in 2021 and is projected to reach US$ 9761.6 million by 2028, at a CAGR of 14.4% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

In-house Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Next-Generation Sequencing Data Analysis include Thermo Fisher Scientific, Inc., QIAGEN, Illumina, Inc., F. Hoffmann-La Roche Ltd., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., PierianDx, Intrexon Bioinformatics Germany GmbH and Partek, Inc., etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the Next-Generation Sequencing Data Analysis companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Next-Generation Sequencing Data Analysis Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Next-Generation Sequencing Data Analysis Market Segment Percentages, by Type, 2021 (%)

In-house

Outsourced

Global Next-Generation Sequencing Data Analysis Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Next-Generation Sequencing Data Analysis Market Segment Percentages, by Application, 2021 (%)

Academic Research

Clinical Research

Hospitals & Clinics

Pharma & Biotech Entities

Other Users

Global Next-Generation Sequencing Data Analysis Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Next-Generation Sequencing Data Analysis Market Segment Percentages, By Region and Country, 2021 (%)

North America

US

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Nordic Countries

Benelux

Rest of Europe

Asia

China

Japan

South Korea

Southeast Asia

India

Rest of Asia

South America

Brazil

Argentina

Rest of South America

Middle East & Africa

Turkey

Israel

Saudi Arabia

UAE

Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Next-Generation Sequencing Data Analysis revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Next-Generation Sequencing Data Analysis revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

Thermo Fisher Scientific, Inc.

QIAGEN

Illumina, Inc.

F. Hoffmann-La Roche Ltd.

Agilent Technologies, Inc.

Bio-Rad Laboratories, Inc.

PierianDx

Intrexon Bioinformatics Germany GmbH

Partek, Inc.

Eurofins Scientific

Pacific Biosciences of California, Inc.

DNASTAR, Inc.

Congenica Ltd.

Fabric Genomics, Inc.

Genuity Science

DNAnexus Inc.

SciGenom Labs Pvt. Ltd.

Golden Helix, Inc.

The Beijing Genomics Institute

LifeTech

Berry Genomics

Da An Gene